Una candidatura hecha para este puesto de trabajo: un currículum y una carta de presentación adaptados que responden directamente a la oferta.
BeOne is seeking a Clinical Research Associate (CRA) to monitor oncology/hematology trials across the region, ensuring adherence to ICH-GCP, local regulations and SOPs. You will perform feasibility, site identification, initiation, routine monitoring and closeout visits, while maintaining study timelines and quality.
Responsibilities include coordinating with the Regional Clinical Operations Manager, supporting site training, and driving CAPA where needed.
BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our passionate interest in fighting cancer.
The CRA executes clinical monitoring activities at clinical trial sites and monitors clinical trials in accordance with ICH guidelines and GCP, local regulations, and applicable SOPs.
Performs monitoring activities related to selection, initiation, conduct (recruitment, quality data collection) and timely completion of oncology/hematology clinical trials within the assigned region.
The CRA is responsible for collaborating closely with the Regional Clinical Operations Manager to ensure study timelines are adhered to and required quality standards are maintained.
Identify gaps and areas for improvement and propose CAPA.
Supports start-up and provides local expertise.
SSU experience is considered a plus
N/A
Efficient in Microsoft Word, Excel, MS Project, MS PowerPoint and Outlook
Travel: Yes
41,400.00 EUR - 51,800.00 EUR
We are proud to be an equal opportunity employer. BeOne does not discriminate on the basis of race, religion, color, sex, gender identity, sexual orientation, age, disability, national origin, veteran status or any other basis covered by appropriate law. All employment is decided on the basis of qualifications, merit, and business need.